Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name
Tikosyn by Pfizer, and is available in the United States in capsules containing ...
TIKOSYN® (dofetilide) is a medicine for highly symptomatic atrial fibrillation (
irregular heartbeats). See the risks & benefits of TIKOSYN®.
Learn about Tikosyn (Dofetilide) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.
Find a comprehensive guide to possible side effects including common and rare
side effects when taking Tikosyn (Dofetilide) for healthcare professionals and ...
Description, Dofetilide is a class III antiarrhythmic agent that is approved by the
Food and Drug Administration (FDA) for the maintenance of sinus rhythm in ...
Find patient medical information for dofetilide oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Mar 15, 2001 ... On October 1, 1999, the U.S. Food and Drug Administration (FDA) approved
dofetilide (Tikosyn) for the treatment of persistent (nonparoxysmal) ...
Jun 15, 2016 ... Dofetilide is a class III antiarrhythmic agent (table 1) available for use in the
United States and other countries for the acute termination of atrial ...
Medscape - Atrial fibrillation dosing for Tikosyn, (dofetilide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
TIKOSYN® (dofetilide) is an antiarrhythmic drug with Class III (cardiac action
potential duration prolonging) properties. Its empirical formula is